Skip to main content
Caplight Logo









MetasTx, LLC

MetasTx, LLC

Private
Pittsburgh, PennsylvaniaHealthcare & Life Scienceshttps://metastx.com/

Last Round

Grant

Jun 25, 2025

Total Funding Raised

$600,000

Company Overview

MetasTx, LLC is a biopharmaceutical company that develops novel therapeutics and diagnostic tools to treat and prevent the metastasis of solid tumor cancers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

precision oncologymetastasis preventioncompanion diagnosticdrug discoverytargeted therapycancer diagnosticsbiotechai drug discoveryprostate cancer treatmentmolecular diagnosticsclinical-stage biopharmasmall molecule inhibitorsgenerative ai for sciencesbirgenai

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MetasTx, LLC Comparables

Compare MetasTx, LLC with similar companies based on industry and business-model similarity.

MetasTx, LLC comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Chosa Oncology AB
71%
Myriad Genetics
68%
Veracyte
68%

MetasTx, LLC Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 25, 2025
SeedJun 1, 2025
Pre SeedJun 1, 2025
AcceleratorDec 6, 2023
Pre SeedAug 22, 2022
Seed
Jun 7, 2022

Key People

Founding team and executive leadership

Harvey Homan

Chief Executive Officer

Executive Team

MetasTx, LLC Investors

Notable investors and investment history

MetasTx, LLC investors
InvestorRounds
AlphaLab HealthAccelerator
National Cancer InstituteGrant
AHNAccelerator
Georgia Research AllianceSeed
Accelerator Venture PartnersPre Seed
Innovation WorksAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 25, 2025

    $500K grant received from the National Cancer Institute.

  • Jun 1, 2025

    $500K raised in Pre Seed round.

MetasTx, LLC Filings

Explore SEC and related filing metadata, where available.

MetasTx, LLC filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about MetasTx, LLC's valuation, stock price, and market status.

Is MetasTx, LLC a public or private company?

MetasTx, LLC is a private company.

What is the current stock price of MetasTx, LLC?

MetasTx, LLC is a private company with no public stock price. No recent secondary market data is available.

How much is MetasTx, LLC worth (valuation)?

Valuation information for MetasTx, LLC is not publicly available.

Can I buy MetasTx, LLC stock?

MetasTx, LLC shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was MetasTx, LLC's last funding round?

MetasTx, LLC's most recent funding round was Grant on June 25, 2025.

Who are the main investors in MetasTx, LLC?

Key investors in MetasTx, LLC include AlphaLab Health, National Cancer Institute, AHN, Georgia Research Alliance, Accelerator Venture Partners.

Will MetasTx, LLC IPO soon?

No public IPO plans have been announced for MetasTx, LLC.

How can I track MetasTx, LLC secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MetasTx, LLC's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPittsburgh, Pennsylvania
Employee Range2
Year Founded2021
Last FundingJun 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?